Table A.4.
WTCHR (n=60) | Russian Children's Study (n=482) | |||
---|---|---|---|---|
median (25th, 75th percentile) | median TEQ* | median (25th, 75th percentile) | median TEQ* | |
Serum polychlorinated dibenzo-p-dioxins (PCDDs) (pg/g lipid) | ||||
2,3,7,8-TCDD | 1.71 (0.74, 20.2) | 1.71 | 2.75 (1.34, 3.90) | 2.75 |
1,2,3,7,8-PenCDD | 14.1 (0.65, 34.4) | 14.1 | 4.10 (1.41, 7.00) | 4.10 |
1,2,3,4,7,8-HexCDD | 0.01 (0.01, 12.5) | 0.001 | 2.00 (0.71, 3.90) | 0.20 |
1,2,3,6,7,8-HexCDD | 0.02 (0.02, 0.04) | 0.002 | 8.70 (5.40, 16.6) | 0.87 |
1,2,3,7,8,9-HexCDD | 14.4 (10.3, 27.0) | 1.44 | 2.61 (0.85, 4.60) | 0.26 |
1,2,3,4,6,7,8-HepCDD | 23.5 (14.0, 47.2) | 0.23 | 12.2 (8.20, 19.5) | 0.12 |
OCDD | 135 (64.8, 394) | 0.04 | 96.1 (69.0, 134) | 0.03 |
Σ PCDD | 197 (128, 580) | 17.5 | 136 (93, 189) | 8.2 |
Serum polychlorinated dibenzofurans (PCDFs) (pg/g lipid) | ||||
2,3,7,8-TCDF | 29.1 (15.5, 48.9) | 2.91 | 0.50 (0.42, 1.63) | 0.05 |
1,2,3,7,8-PenCDF | 13.2 (0.01, 28.9) | 0.40 | 0.57 (0.42, 1.91) | 0.02 |
2,3,4,7,8-PenCDF | 12.1 (0.24, 22.3) | 3.64 | 9.0 (6.20, 14.6) | 2.70 |
1,2,3,4,7,8-HexCDF | 0.03 (0.02, 13.4) | 0.0003 | 6.65 (4.10, 12.5) | 0.67 |
1,2,3,6,7,8-HexCDF | 0.02 (0.02, 0.05) | 0.0002 | 4.20 (2.90, 6.70) | 0.42 |
2,3,4,6,7,8-HexCDF | 0.01 (0.01, 0.01) | 0.0001 | 0.57 (0.42, 1.41) | 0.06 |
1,2,3,7,8,9-HexCDF | 6.29 (0.02, 33.2) | 0.06 | 0.57 (0.42, 1.84) | 0.06 |
1,2,3,4,6,7,8-HepCDF | 77.5 (41.4, 161) | 0.77 | 7.50 (5.47, 11.3) | 0.08 |
1,2,3,4,7,8,9-HepCDF | 0.01 (0.01, 0.01) | 0.0001 | 0.64 (0.50, 2.26) | 0.01 |
OCDF | 26.4 (0.01, 110) | 0.01 | 2.90 (1.80, 5.00) | 0.001 |
Σ PCDF | 232 (127, 449) | 7.79 | 39 (27, 57) | 4.2 |
WTCHR: World Trade Center Health Registry; TEQ: toxic equivalency quotient
based on 2005 World Health Organization toxic equivalency factors